Company Overview of FoldRx Pharmaceuticals, Inc.
FoldRx Pharmaceuticals, Inc. discovers and develops disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The company’s pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson's disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts. As of October 6, 2010, FoldRx Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.
100 Acorn Park Drive
Cambridge, MA 02140
Founded in 2003
Key Executives for FoldRx Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Tragara Pharmaceuticals, Inc.||United States|
|Bergstrom Nutrition, Inc.||United States|
|Olympian Labs, Inc.||United States|
|Berkeley Advanced Biomaterials, Inc.||United States|
|Elan Holdings, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact FoldRx Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.